HFX AdaptivAI combines insights from more than 100 million data points and more than 100,000 patients for responsive and personalized pain relief, according to a news release. The spinal cord stimulator provides real-time insights and remote monitoring for physicians.
Nevro plans a full U.S. market release of HFX iQ with HFX AdaptiveAI in the fourth quarter of 2024.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
